Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet’s Disease

Shimizu, Jun; Izumi, Tomoko; Suzuki, Noboru

doi:https://doi.org/10.1155/2012/105205

Autoimmune Diseases

On this page

Abstract Introduction Conclusions Acknowledgments References Copyright Related Articles

Special Issue

Heat-shock Proteins in Autoimmunity

View this Special Issue

Review Article | Open Access

Volume 2012 | Article ID 105205 | https://doi.org/10.1155/2012/105205

Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet’s Disease

Jun Shimizu,¹Tomoko Izumi,^1,2and Noboru Suzuki¹

Academic Editor: Kamal D. Moudgil

Received16 Jul 2012

Accepted23 Aug 2012

Published02 Oct 2012

Abstract

Behcet’s disease (BD) is a multisystemic inflammatory disease and is characterized by recurrent attacks on eyes, brain, skin, and gut. There is evidence that skewed T-cell responses contributed to its pathophysiology in patients with BD. We found that heat shock proteins (HSPs) reactive T cells were prevalent in patients with BD. Here, we summarize current findings on HSP reactive T cells and their contribution to the pathogenesis in patients with BD.

1. Introduction

Behcet’s disease (BD) is a systemic inflammatory disease, characterized by recurrent signs and symptoms of oral aphthosis, genital ulcers, skin lesions, and uveitis. It is well known that BD is prevalent along the Silk Route, but BD patients are occasionally found in other regions of the world.

The etiology of BD is largely unknown and skewed T-cell responses are associated with development and maintenance of BD [1]. Excessive cytokine productions by T helper type 1 (Th1) cells were reported using immunohistochemistry [2, 3] and intracellular cytokine staining [4, 5]. Th1 dominance was observed in BD uveitis [6] and stomatitis as well [7]. We reported excessive Th1 cell infiltration in BD skin and intestinal lesions [8–10].

Immune responses against microbes and microbial antigens were thought to play an important role in the pathogenesis of BD. Regional differences of the disease distribution [11] suggested association of disease development with locally prevalent microbes. Oral health was often impaired in patients with BD and was correlated well with BD disease severity [12]. Streptococcus sanguinis is a commensal oral bacterium and often forms dental plaque. S. sanguinis was found frequently in oral flora in patients with BD and the strain showed uncommon serotype (KTH1) compared with the standard ATCC strains [13]. T cells and peripheral blood mononuclear cells (PBMCs) from patients with BD responded to KTH1 antigens and produced interferon γ (IFNγ) and interleukin (IL)-12 [14]. Skin tests of streptococcal antigens caused various systemic reactions, such as fever, ocular attack, and genital and oral ulcer in patients with BD [15]. Accumulation of indirect evidence suggested participation of bacteria (or associated antigens) in the pathogenesis of BD.

Pathergy reaction is a cutaneous phenomenon where a minor injury, such as a needle prick, causes major skin lesions, such as ulcerations, panniculitis, and pyoderma, and positive pathergy reaction is included in the diagnostic criteria for BD proposed by the International Study Group [16]. Massive neutrophil infiltration and subsequent T-cell infiltration were frequently observed pathologically in the lesion caused by the reaction, even without any exogenous microbes [2]. The underlying mechanisms of the reaction remain largely unknown. On the other hand, it was suggested that skin florae and some skin self-antigens played a role because bacterial sterilization of skin reduced the reaction [17].

Heat shock proteins (HSPs) function as an intracellular chaperonin for other proteins, and significant sequence homology is found between mammalian HSP and microbial HSP (Table 1). For example, mycobacterial and streptococcal HSP65 have more than 90% homology, and mycobacterial HSP65 and human HSP60 have 42% homology [18]. HSP60/65 were thought to be a major cause of the autoimmunity in patients with BD because of the molecular mimicry between human and microbial HSP. In this paper, we summarize current understanding of T-cell responses against HSP in patients with BD.

2. HSP Expressions in BD Lesions

Lehner et al. found that monoclonal antibodies against HSP65 reacted with six S. sanguinis strains and Streptococcus pyogenes [19]. They revealed that both IgG and IgA antibodies against HSP65 and S. sanguinis were significantly increased in BD patients compared to normal controls. They showed molecular mimicry between HSP and streptococcal antigens and suggested HSP-antigen-specific autoimmunity in the pathogenesis of BD.

After the initial report, researchers tried to identify the expression of HSP and to analyze immune cell functions on biopsy specimens in patients with BD. Several researchers observed massive expressions of HSP60 in BD skin [23] and oral ulcer lesions [24, 25]. HSP60 was expressed more diffusely [25] and intensely [23, 25] in BD lesions than those in other types of inflammation, such as oral lichen planus and recurrent aphthous stomatitis. Not only infiltrating cells but also vascular endothelial and epithelial cells expressed HSP60 in the BD skin lesions [25].

We reported excessive Th1 cell function and aberrant HSP expression in patients with BD [8–10]. HSP60 mRNA expression was found in PBMC and in intestinal tissues of BD but not in those of normal controls [8]. We found that infiltrating mononuclear cells, including CD4+ T cells, CD8+ T cells, and CD68+ macrophages, expressed HSP60, IFNγ, and IL-12 in the intestinal lesions in patients with BD [8, 9]. C-C type chemokine receptor (CCR)5 and macrophage inflammatory protein (MIP)1β, a Th1-related chemokine receptor and its ligand, were detected in the intestinal lesions in patients with BD, and we suggested that CCR5/MIP1β interaction played a role in the migration of activated Th1 cells [8]. It is possible that HSP60 acted as a crucial signal to trigger excessive Th1 cell accumulation and subsequent Th1-cell-mediated inflammatory responses in the intestinal lesions in patients with BD where activated T cells and macrophages promoted the destructive processes.

3. T-Cell Responses against HSP Peptides in Patients with BD

Lehner et al. analyzed the frequency of short-term cell lines stimulated with four selected peptides (111–125, 154–172, 219–233, 311–326) (Figure 1, Table 2) derived from Mycobacterium tuberculosis HSP65 in the ocular, arthritic, and mucocutaneous types of BD. T cells from ocular-type BD patients responded excessively to the stimulation with the four HSP peptides, especially peptides 111–125 and 311–326 [20].

Excessive T- and B-cell responses to the four peptides and human counterparts were observed in patients with BD who lived in Europe, Far Eastern Asia, and the Middle East [10, 20–22].

In our study, CD4+ T cells, but not CD8+ T cells, yielded proliferative responses to the peptide 336–351 derived from human HSP60 in Japanese BD patients [26]. We evaluated T-cell receptor Vβ gene usage of T cells which responded to the peptide 336–351 in the patients [22]. To this end, we first conducted amplification by PCR of TCR Vβ gene of T cells which had been stimulated with the peptide in vitro and then visualized several bands which represented each TCR clonotype by PCR-single-strand conformation polymorphism (SSCP) based technique. T-cell receptor Vβ gene oligoclonality was found in T cells which had been freshly isolated from peripheral blood and the exactly same PCR products were remarkably increased after stimulation with the peptide 336–351 in patients with BD. These data suggested that HSP-specific T cells in patients with BD showed antigen-driven expansion by HSP stimulation and that the HSP peptide reactive T cells increased in BD peripheral blood. A longitudinal study of the TCR clonotypes in 6 BD patients showed that the oligoclonal expansion of particular T-cell clonotypes correlated with the severity of uveitis [22].

4. T-Cell Activation and HSP60/65

HSP60/65 presented by antigen presenting cells (APCs) stimulated not only αβ T cells but also γδ T cells which played important roles in the oral mucosal immunity as the first defense against microorganisms. It was thought that Vγ9δ2+ T cells, a major subset of γδ T cells of peripheral blood lymphocytes (PBL), recognized the antigens produced by bacteria [26]. Vδ1+ γδ T cells responded to the stress inducible major histocompatibility complex class I related chain A (MICA) mainly expressed on damaged intestinal epithelial cells [28].

Vδ2+ γδ T cells increased in peripheral blood, while Vδ1+ γδ T cells increased in bronchoalveolar lavage fluid and cerebrospinal fluid in patients with BD [29]. Infiltrating cells expressed HSP, and γδ T-cell numbers were increased in oral ulcer in the patients [23, 25].

We found that CD45RA+ Vγ9δ2+ γδ T cells increased in BD PBL irrespective of disease activity. Vγ9δ2+ γδ T cells in the active phase of BD expressed IL-2 receptor β chain and HLA-DR, suggesting that the cells were activated in vivo [30]. The CD45RA+ γδ T cells produced tumor necrosis factor (TNF)α and contained perforin granules. Moreover, Vγ9δ1+ γδ T cells preferentially responded to S. sanguinis-derived KTH1 antigen without HLA restriction [31]. It is possible that γδ T cells respond to HSP both in peripheral blood and in affected lesions and enhance the inflammation in patients with BD.

5. Th17 Cells and HSP

Recently, the classical Th1/Th2 paradigm was challenged by the discovery of various subsets of T helper cells [27] (Figure 2). Th17 cells produce a number of proinflammatory cytokines, including IL-17, IL-17F, IL-21, and IL-22. IL-6, IL-21, and transforming growth factor (TGF)β were reported to play a role in the differentiation of Th17 cells which proliferated in the presence of IL-23. Regulatory T (Treg) cells control T-cell immune responses and also need TGFβ for their differentiation [27] (Figure 2).

TGFβ activates Smad pathway via TGFβ receptor I/II complex and activated Smad protein leads to forkhead box P3 (Foxp3) expression which is a master gene of Treg cells [32] (Figure 3). TGFβ also activates p38 mitogen-activated protein kinase (MAPK) which regulates Th17 cell differentiation [32, 33]. In the presence of TGFβ, IL-6/STAT3 signaling pathway plays a critical role in the reduction of Foxp3 expression and in the induction of retinoic acid receptor-related orphan receptor C (RORC) expression which is a master gene of Th17 cells [34] (Figure 3). Also it is reported that STAT3 and MAPK are involved in the immune tolerance induction and Treg cell differentiation [35, 36]. Signaling molecules such as STAT3 and MAPK may transduce positive and negative signals depending upon the surrounding microenvironment. To address these issues, further studies are needed. In addition, specific antigen such as HSP directly and indirectly regulated the balance between Th17 and Treg cells [37–40].

Figure 3

A schematic representation of skewed Th17/Treg cell differentiation in patients with BD, a hypothesis. TGFβ activates Smad pathway via TGFβ receptor I/II complex, and activated Smad protein leads to forkhead box P3 (Foxp3) expression which is a master gene of Treg cells [27]. TGFβ also activates p38 mitogen-activated protein kinase (MAPK) which regulates Th17 cell differentiation [32, 33]. In the presence of TGFβ, IL-6/STAT3 signaling pathway plays a critical role in the reduction of Foxp3 expression and in the induction of retinoic acid receptor-related orphan receptor C (RORC) expression which is a master gene of Th17 cells [34]. In patients with BD, monocytes and T cells overproduce IL-6 in the presence of HSP [41]. Overexpression of RORC [42, 43], underexpression of Foxp3 [44, 45], and higher frequencies of Th17 cells [42–44, 46] are reported in patients with BD. PHA: phytohemagglutinin, TGFβRI/II: TGFβ receptor types I and II, STAT3: signal transducer and activator of transcription 3.

In patients with BD, monocytes and T cells overproduced IL-6 in the presence of HSP [41]. Overexpression of RORC mRNA [42, 43], underexpression of Foxp3 [44, 45], and high frequencies of Th17 cells [42–44, 46] were reported in patients with BD. We recently reported that TGFβ/Smad signaling pathway of T cells was overactivated in patients with BD [47]. We also reported the possibility that CD4+ T cells in patients with BD showed higher sensitivity to IL-23 and produced more IFNγ and IL-17, as compared with normal controls [43]. Recent genome-wide association studies identified IL-12 receptor β2 (IL-12Rβ2)/IL-23 receptor and IL-10 genes as BD susceptibility genes [48, 49]. Based on the above findings, we proposed that HSP induced imbalance of Th17 cells to Treg cells in patients with BD (Figure 3). Further study on HSP and Th17 cell differentiation is necessary to understand the pathogenesis of BD.

6. Toll-Like Receptors (TLRs) and HSP60/65

TLRs play a key role in recognition of microbes in the innate immune system. Activation of dendritic cells by TLR ligands is a crucial event in the initiation of both innate and adaptive immune responses. Several classes of TLR ligands are identified which interact with distinct members of the TLR family. TLR2/CD14 complex and TLR4/CD14 complex were suggested to be important for APC to recognize HSP60 [50], and TLR2/6 heterodimer was reported to promote IL-6 production of mononuclear cells [51]. We need to study the expression of the heterodimer because IL-6 concentrations were elevated in patients with BD [41].

We found that TLR2 and TLR4 mRNA were expressed on ileocaecal ulcer lesions of BD, but less on unaffected sites of BD and on Crohn’s disease lesions. We found that IL-12 producing TLR2+ macrophages are located neighboring to CD3+ T cells. HSP60 was expressed on the same region of the intestinal lesions [9]. We suggested that TLR/HSP60 interactions induced destructive Th1-type responses at the intestinal lesion in patients with BD.

7. Conclusions

We reviewed here HSPs reactive T-cells and their contribution to the pathogenesis of BD. It is possible that HSPs regulate T-cell differentiation through several interactions. The interactions between TCR- and HSP-derived peptides on MHC [22] and between IL-12 and its receptor [8–10] may induce aberrant T-cell differentiation in patients with BD (Figure 4). The interaction between MIP1β and CCR5 was suggested to induce migration of the pathogenic T cells [8]. TLR2/6 heterodimer is involved in IL-6 production [51] and thus we need to study the expression of the heterodimer in patients with BD. It is important to clarify whether HSP bring about generation of pathogenic Th17 cells in patients with BD because Th1 and Th17 cells share a common structure (IL-12Rβ1) on their characteristic receptor complexes, namely, IL-12R and IL-23R [52].

Figure 4

HSP60 regulates Th1 cell differentiation through multiple pathways, a hypothesis. The interactions between TCR- and HSP-derived peptides on MHC [22] and between IL-12 and its receptor [8–10] may induce aberrant T-cell differentiation in patients with BD (Figure 4). The interaction between MIP1β and C-C-type chemokine receptor (CCR)5 was suggested to induce migration of the pathogenic T cells [8]. TLR2/6 heterodimer is involved in IL-6 production [51] and thus we need to study the expression of the heterodimer in patients with BD.

Acknowledgments

This work was supported in part by grants from Behcet’s Disease Research Committee, Research on Specific Disease of the Health Science Research Grants from the Ministry of Health, Labor and Welfare, Japan.

References

T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Behcet's disease,” The New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999.
View at: Publisher Site | Google Scholar
M. Melikoglu, S. Uysal, J. G. Krueger et al., “Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers,” Journal of Immunology, vol. 177, no. 9, pp. 6415–6421, 2006.
View at: Google Scholar
M. Ben Ahmed, H. Houman, M. Miled, K. Dellagi, and H. Louzir, “Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease,” Arthritis and Rheumatism, vol. 50, no. 7, pp. 2291–2295, 2004.
View at: Publisher Site | Google Scholar
S. Koarada, Y. Haruta, Y. Tada et al., “Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behçet's disease,” Rheumatology, vol. 43, no. 7, pp. 843–851, 2004.
View at: Publisher Site | Google Scholar
H. Houman, A. Hamzaoui, I. Ben Ghorbal, M. Khanfir, M. Feki, and K. Hamzaoui, “Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations,” Journal of Autoimmunity, vol. 23, no. 3, pp. 267–273, 2004.
View at: Publisher Site | Google Scholar
F. Ilhan, T. Demir, P. Türkçüoǧlu, B. Turgut, N. Demir, and A. Gödekmerdan, “Th1 polarization of the immune response in uveitis in Behçet's disease,” Canadian Journal of Ophthalmology, vol. 43, no. 1, pp. 105–108, 2008.
View at: Publisher Site | Google Scholar
A. M. Dalghous, J. Freysdottir, and F. Fortune, “Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD,” Scandinavian Journal of Rheumatology, vol. 35, no. 6, pp. 472–475, 2006.
View at: Publisher Site | Google Scholar
Y. Imamura, M. S. Kurokawa, H. Yoshikawa et al., “Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet's disease,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 371–378, 2005.
View at: Publisher Site | Google Scholar
K. Nara, M. S. Kurokawa, S. Chiba et al., “Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease,” Clinical and Experimental Immunology, vol. 152, no. 2, pp. 245–251, 2008.
View at: Publisher Site | Google Scholar
H. Nagafuchi, M. Takeno, H. Yoshikawa et al., “Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease,” Clinical and Experimental Immunology, vol. 139, no. 2, pp. 363–370, 2005.
View at: Publisher Site | Google Scholar
J. Y. Choe, W. T. Chung, S. W. Lee et al., “Regional distinction for the clinical severity of Behçet's disease in Korea: four university-based medical centre studies,” Clinical and Experimental Rheumatology, vol. 28, no. 4, supplement 60, pp. S20–S26, 2010.
View at: Google Scholar
G. Mumcu, T. Ergun, N. Inanc et al., “Oral health is impaired in Behçet's disease and is associated with disease severity,” Rheumatology, vol. 43, no. 8, pp. 1028–1033, 2004.
View at: Publisher Site | Google Scholar
K. Yokota, S. Hayashi, Y. Araki et al., “Characterization of Streptococcus sanguis isolated from patients with Behcet's disease,” Microbiology and Immunology, vol. 39, no. 9, pp. 729–732, 1995.
View at: Google Scholar
H. Yanagihori, N. Oyama, K. Nakamura, N. Mizuki, K. Oguma, and F. Kaneko, “Role of IL-12B promoter polymorphism in Adamantiades-Behcet's disease susceptibility: an involvement of Th1 immunoreactivity against Streptococcus sanguinis antigen,” Journal of Investigative Dermatology, vol. 126, no. 7, pp. 1534–1540, 2006.
View at: Publisher Site | Google Scholar
Y. Mizushima, K. Hoshi, T. Matsuda et al., “Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behcet's disease—a multicenter study,” Journal of Rheumatology, vol. 16, no. 4, pp. 506–511, 1989.
View at: Google Scholar
International Study Group for Behçet's Disease, “Criteria for diagnosis of Behçet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990.
View at: Google Scholar
I. Fresko, H. Yazici, M. Bayramicli, S. Yurdakul, and C. Mat, “Effect of surgical cleaning of the skin on the pathergy phenomenon in Behcet's syndrome,” Annals of the Rheumatic Diseases, vol. 52, no. 8, pp. 619–620, 1993.
View at: Google Scholar
A. K. Dudani and R. S. Gupta, “Immunological characterization of a human homolog of the 65-kilodalton mycobacterial antigen,” Infection and Immunity, vol. 57, no. 9, pp. 2786–2793, 1989.
View at: Google Scholar
T. Lehner, E. Lavery, R. Smith, R. van der Zee, Y. Mizushima, and T. Shinnick, “Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behcet's syndrome,” Infection and Immunity, vol. 59, no. 4, pp. 1434–1441, 1991.
View at: Google Scholar
K. Pervin, A. Childerstone, T. Shinnick et al., “T cell epitope expression of mycobacterial and homologous human 65- kilodalton heat shock protein peptides in short term cell lines from patients with Behcet's disease,” Journal of Immunology, vol. 151, no. 4, pp. 2273–2282, 1993.
View at: Google Scholar
H. Direskeneli, E. Ekşioǧlu-Demiralp, S. Yavuz et al., “T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behcet's disease,” Journal of Rheumatology, vol. 27, no. 3, pp. 708–713, 2000.
View at: Google Scholar
S. Kaneko, N. Suzuki, N. Yamashita et al., “Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan,” Clinical and Experimental Immunology, vol. 108, no. 2, pp. 204–212, 1997.
View at: Google Scholar
T. Ergun, Ü. Ince, E. Ekşioǧlu-Demiralp et al., “HSP 60 expression in mucocutaneous lesions of Behçet's disease,” Journal of the American Academy of Dermatology, vol. 45, no. 6, pp. 904–909, 2001.
View at: Publisher Site | Google Scholar
E. Deniz, U. Guc, N. Buyukbabani, and A. Gul, “HSP 60 expression in recurrent oral ulcerations of Behet's disease,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontology, vol. 110, no. 2, pp. 196–200, 2010.
View at: Publisher Site | Google Scholar
T. E. Bramanti, N. P. Dekker, F. Lozada-Nur, J. J. Sauk, and J. A. Regezi, “Heat shock (stress) proteins and γδ T lymphocytes in oral lichen planus,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontology, vol. 80, no. 6, pp. 698–704, 1995.
View at: Google Scholar
B. Altincicek, J. Moll, N. Campos et al., “Cutting edge: human γδ T cells are activated by intermediates of 2-C-methyl-D-erythritol 4-phosphate pathway of isoprenoid biosynthesis,” Journal of Immunology, vol. 166, no. 6, pp. 3655–3658, 2001.
View at: Google Scholar
M. T. Palmer and C. T. Weaver, “Autoimmunity: increasing suspects in the CD4 + T cell lineup,” Nature Immunology, vol. 11, no. 1, pp. 36–40, 2010.
View at: Publisher Site | Google Scholar
V. Groh, A. Steinle, S. Bauer, and T. Spies, “Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells,” Science, vol. 279, no. 5357, pp. 1737–1740, 1998.
View at: Publisher Site | Google Scholar
K. Hamazaoui, A. Hamazaoui, F. Hentati “ et al., “Phenotype and functional profile of T cells expressing γδ receptor from patients with active Behçet’s disease,” Journal of Rheumatology, vol. 21, no. 12, pp. 2301–2306, 1994.
View at: Google Scholar
N. Yamashita, H. Kaneoka, S. Kaneko et al., “Role of γδ T lymphocytes in the development of Behcet's disease,” Clinical and Experimental Immunology, vol. 107, no. 2, pp. 241–247, 1997.
View at: Google Scholar
M. Mochizuki, N. Suzuki, M. Takeno et al., “Fine antigen specificity of human γδ T cell lines (Vγ9+) established by repetitive stimulation with a serotype (KTH-1) of a gram-positive bacterium, Streptococcus sanguis,” European Journal of Immunology, vol. 24, no. 7, pp. 1536–1543, 1994.
View at: Publisher Site | Google Scholar
L. Lu, J. Wang, F. Zhang et al., “Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells,” Journal of Immunology, vol. 184, no. 8, pp. 4295–4306, 2010.
View at: Publisher Site | Google Scholar
R. Noubade, D. N. Krementsov, R. Del Rio et al., “Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis,” Blood, vol. 118, no. 12, pp. 3290–3300, 2011.
View at: Google Scholar
E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006.
View at: Publisher Site | Google Scholar
R. Wang, G. Han, J. Wang et al., “The role of STAT3 in antigen-IgG inducing regulatory CD4+Foxp3+T cells,” Cellular Immunology, vol. 246, no. 2, pp. 103–109, 2007.
View at: Publisher Site | Google Scholar
S. Huber, J. Schrader, G. Fritz et al., “P38 MAP kinase signaling is required for the conversion of CD4+CD25 - T cells into iTreg,” PLoS ONE, vol. 3, no. 10, Article ID e3302, 2008.
View at: Publisher Site | Google Scholar
A. Zanin-Zhorov, L. Cahalon, G. Tal, R. Margalit, O. Lider, and I. R. Cohen, “Heat shock protein 60 enhances CD4+CD25+ regulatory T cell function via innate TLR2 signaling,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 2022–2032, 2006.
View at: Publisher Site | Google Scholar
S. Pawaria and R. J. Binder, “CD91-dependent programming of T-helper cell responses following heat shock protein immunization,” Nature Communications, vol. 2, article 521, 2011.
View at: Publisher Site | Google Scholar
G. H. M. van Puijvelde, T. van Es, E. J. A. van Wanrooij et al., “Induction of oral tolerance to HSP60 or an HSP60-peptide activates t cell regulation and reduces atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2677–2683, 2007.
View at: Publisher Site | Google Scholar
Y. T. Lin, C. T. Wang, M. E. Gershwin, and B. L. Chiang, “The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis,” Autoimmunity Reviews, vol. 10, no. 8, pp. 482–489, 2011.
View at: Publisher Site | Google Scholar
S. Pay, I. Şimşek, H. Erdem, and A. Dinç, “Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells,” Rheumatology International, vol. 27, no. 5, pp. 417–424, 2007.
View at: Publisher Site | Google Scholar
K. Hamzaoui, E. Bouali, I. Ghorbel, M. Khanfir, H. Houman, and A. Hamzaoui, “Expression of Th-17 and RORγt mRNA in Behçet's Disease,” Medical Science Monitor, vol. 17, no. 4, pp. CR227–CR234, 2011.
View at: Google Scholar
J. Shimizu, K. Takai, N. Fujiwara et al., “Excessive CD4+ T cells co-expressing interleukin-17 and interferon-ã in patients with Behçet's disease,” Clinical and Experimental Immunology, vol. 168, no. 1, pp. 68–74, 2012.
View at: Google Scholar
G. Geri, B. Terrier, M. Rosenzwajg et al., “Critical role of IL-21 in modulating TH17 and regulatory Tcells in Behçet disease,” Journal of Allergy and Clinical Immunology, vol. 128, no. 3, pp. 655–664, 2011.
View at: Publisher Site | Google Scholar
Y. Nanke, S. Kotake, M. Goto, H. Ujihara, M. Matsubara, and N. Kamatani, “Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: a possible predictive marker of ocular attack,” Modern Rheumatology, vol. 18, no. 4, pp. 354–358, 2008.
View at: Publisher Site | Google Scholar
W. Chi, X. Zhu, P. Yang et al., “Upregulated IL-23 and IL-17 in Behçet patients with active uveitis,” Investigative Ophthalmology and Visual Science, vol. 49, no. 7, pp. 3058–3064, 2008.
View at: Publisher Site | Google Scholar
J. Shimizu, T. Izumi, N. Arimitsu et al., “Skewed TGFβ/Smad signaling pathway of T cells in patients with Behcet’s disease,” Clinical and Experimental Rheumatology. In press.
View at: Google Scholar
N. Mizuki, A. Meguro, M. Ota et al., “Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci,” Nature Genetics, vol. 42, no. 8, pp. 703–706, 2010.
View at: Publisher Site | Google Scholar
E. F. Remmers, F. Cosan, Y. Kirino et al., “Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease,” Nature Genetics, vol. 42, no. 8, pp. 698–702, 2010.
View at: Publisher Site | Google Scholar
A. Kol, A. H. Lichtman, R. W. Finberg, P. Libby, and E. A. Kurt-Jones, “Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells,” Journal of Immunology, vol. 164, no. 1, pp. 13–17, 2000.
View at: Google Scholar
J. Jin, D. J. Samuvel, X. Zhang et al., “Coactivation of TLR4 and TLR2/6 coordinates an additive augmentation on IL-6 gene transcription via p38MAPK pathway in U937 mononuclear cells,” Molecular Immunology, vol. 49, no. 3, pp. 423–432, 2011.
View at: Google Scholar
D. A. Vignali and V. K. Kuchroo, “IL-12 family cytokines: immunological playmakers,” Nature Immunology, vol. 13, no. 8, pp. 722–728, 2012.
View at: Google Scholar

Copyright

Copyright © 2012 Jun Shimizu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1409

Downloads

1387

Citations